gene therapy
ARUP Laboratories Gains IVDR-CE Mark for Hemophilia Gene Therapy CDx
The Salt Lake City-based firm's test is used to identify hemophilia A patients eligible for treatment with BioMarin's Roctavian gene therapy.
William Blair Initiates Coverage of Bio-Techne With Outperform Rating
The investment bank emphasized Bio-Techne's position in multiple high-growth and attractive end markets, including cell and gene therapy, spatial biology, and liquid biopsy.
ARUP Laboratories Gets FDA Approval for Hemophilia Gene Therapy CDx
The test determines whether a patient with hemophilia A have antibodies that could reduce the efficacy of BioMarin Pharmaceutical's Roctavian gene therapy.
Sysmex Gets Approval in Japan for Retinal Dystrophy Gene Panel
The next-generation sequencing panel identifies genetic mutations that cause inherited retinal dystrophy, which results in vision problems, including blindness.
Inherited Retinal Disease Patients, Therapy Developers May Benefit From New Genetic Testing Program
Premium
To study the benefit of genetic testing data, the Foundation Fighting Blindness offered free clinical testing to 100 members of its My Retina Tracker patient registry.